期刊
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
卷 40, 期 2, 页码 107-116出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/08923973.2017.1386212
关键词
Artesunate; gamma delta T cells; cytotoxicity; hepatoma carcinoma cell; immune escape
资金
- Medical Science and Technology Innovation Research Foundation of Nanjing Military Area Command [15MS045]
Objective: To explore the effect and mechanism of artesunate on gamma delta T cell-mediated antitumor immune responses against hepatoma carcinoma cells (HepG2) in vitro. Methods: Human gamma delta T cells or HepG2 were respectively treated with artesunate, subjected to co-culture as appropriate, and the following assays were subsequently conducted: CCK8 to examine cell viability; LDH release assay to detect the killing effect of gamma delta T cells on HepG2 cells; flow cytometry to examine the expression of perforin (PFP) and granzyme B (GraB) of gamma delta T cells; ELISA to evaluate the levels of TGF-beta 1 and IL-10 in the collected supernatant of HepG2 cells pretreated with artesunate; and Western blot analysis to examine Fas, FasL, STAT3, p-STAT3 expression of HepG2 cells induced by artesunate. Results: The results showed that the cytotoxicity effect of gamma delta T cells pretreated with artesunate on HepG2 cells was augmented via elevating the expression of GraB in gamma delta T cells. Furthermore, treatment with artesunate reversed the inhibition of HepG2 cells on gamma delta T cells by reducing the secretion of TGF-beta 1 in HepG2 cells supernatant and enhanced the antitumor effect of gamma delta T cells against HepG2 cells through increasing the expression of Fas on HepG2 cells, which may be attributed to the inhibition of STAT3 signaling protein. Conclusion: Artesunate has several mechanisms for augmenting the antitumor immune responses mediated by gamma delta T cells. These results suggested artesunate may be an efficacious agent in the treatment of hepatocellular carcinoma.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据